Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Date Action Amount Person Type
May 06, 2024 Buy 61 729 Equels Thomas K Common Stock
May 06, 2024 Buy 30 865 Rodino Peter W Iii Common Stock
Mar 21, 2024 Buy 38 462 Bryan Nancy Common Stock
Mar 15, 2024 Buy 90 910 Appelrouth Stewart Common Stock
Mar 15, 2024 Buy 75 758 Equels Thomas K Common Stock
Mar 15, 2024 Buy 37 879 Rodino Peter W Iii Common Stock
Nov 30, 2023 Buy 100 000 Rodino Peter W Iii Options
Nov 30, 2023 Buy 300 000 Equels Thomas K Options
Nov 27, 2023 Buy 33 861 Equels Thomas K Common Stock
Sep 29, 2023 Buy 22 676 Equels Thomas K Common Stock
Aug 25, 2023 Buy 8 222 Equels Thomas K Common Stock
Aug 24, 2023 Buy 14 993 Equels Thomas K Common Stock
Jul 17, 2023 Buy 16 950 Equels Thomas K Common Stock
Mar 28, 2023 Buy 0 Bryan Nancy
Mar 10, 2023 Sell 68 208 Appelrouth Stewart Common Stock
Mar 08, 2023 Buy 25 000 Appelrouth Stewart Options
Mar 08, 2023 Buy 25 000 Appelrouth Stewart Options
Mar 08, 2023 Buy 25 000 Appelrouth Stewart Options
Mar 08, 2023 Buy 2 568 Appelrouth Stewart Options
Mar 08, 2023 Buy 2 356 Appelrouth Stewart Options
Mar 08, 2023 Buy 1 963 Appelrouth Stewart Options
Mar 08, 2023 Buy 1 728 Appelrouth Stewart Options
Mar 08, 2023 Buy 1 136 Appelrouth Stewart Options
Mar 08, 2023 Buy 1 136 Appelrouth Stewart Options
Mar 08, 2023 Buy 1 115 Appelrouth Stewart Options
Mar 08, 2023 Buy 568 Appelrouth Stewart Options
Mar 08, 2023 Buy 338 Appelrouth Stewart Options
Mar 08, 2023 Buy 295 Appelrouth Stewart Options
Mar 08, 2023 Buy 287 Appelrouth Stewart Options
Mar 08, 2023 Buy 250 Appelrouth Stewart Options
Mar 08, 2023 Buy 196 Appelrouth Stewart Options
Mar 08, 2023 Buy 163 Appelrouth Stewart Options
Mar 08, 2023 Buy 150 Appelrouth Stewart Options
Mar 08, 2023 Buy 143 Appelrouth Stewart Options
Mar 08, 2023 Buy 11 Appelrouth Stewart Options
Mar 03, 2023 Buy 50 000 Dickey Robert Iv Options
Jan 03, 2023 Buy 80 646 Appelrouth Stewart Common Stock
Jan 03, 2023 Buy 161 291 Equels Thomas K Common Stock
Jan 03, 2023 Buy 80 646 Rodino Peter W Iii Common Stock
Nov 30, 2022 Buy 100 000 Rodino Peter W Iii Options
Nov 30, 2022 Buy 50 000 Appelrouth Stewart Options
Nov 30, 2022 Buy 300 000 Equels Thomas K Options
Nov 30, 2022 Buy 50 000 Mitchell William M Options
Jul 18, 2022 Buy 32 895 Equels Thomas K Common Stock
Apr 25, 2022 Buy 24 500 Appelrouth Stewart Common Stock
Apr 25, 2022 Buy 4 902 Rodino Peter W Iii Common Stock
Apr 25, 2022 Buy 49 020 Equels Thomas K Common Stock
Apr 04, 2022 Buy 0 Lintal Ellen M
Mar 03, 2022 Buy 50 000 Rodino Peter W Iii Options
Mar 03, 2022 Buy 50 000 Rodino Peter W Iii Options
Mar 03, 2022 Buy 50 000 Mitchell William M Options
Mar 03, 2022 Buy 50 000 Lintal Ellen M Options
Mar 03, 2022 Buy 50 000 Lintal Ellen M Options
Mar 03, 2022 Buy 50 000 Equels Thomas K Options
Mar 03, 2022 Buy 50 000 Equels Thomas K Options
Mar 03, 2022 Buy 50 000 Appelrouth Stewart Options
Dec 13, 2021 Buy 21 552 Equels Thomas K Common Stock
Dec 13, 2021 Buy 21 552 Equels Thomas K Common Stock
Dec 10, 2021 Buy 11 811 Equels Thomas K Common Stock
Dec 10, 2021 Buy 11 811 Equels Thomas K Common Stock
Nov 30, 2021 Buy 100 000 Rodino Iii Peter W. Options
Nov 30, 2021 Buy 100 000 Lintal Ellen M Options
Nov 24, 2021 Buy 19 379 Appelrouth Stewart Common Stock
Nov 24, 2021 Buy 11 627 Equels Thomas K. Common Stock
Nov 23, 2021 Buy 11 194 Equels Thomas K. Common Stock
Nov 19, 2021 Buy 10 204 Equels Thomas K. Common Stock
Nov 17, 2021 Buy 9 146 Equels Thomas K. Common Stock
Nov 11, 2021 Buy 50 000 Mitchell William M Options
Nov 11, 2021 Buy 50 000 Appelrouth Stewart Options
Nov 11, 2021 Buy 300 000 Equels Thomas K. Options
Jul 16, 2021 Buy 15 625 Equels Thomas K. Common Stock
Feb 25, 2021 Buy 10 638 Appelrouth Stewart Common Stock
Feb 24, 2021 Buy 11 062 Equels Thomas K. Common Stock
Dec 17, 2020 Buy 14 535 Equels Thomas K. Common Stock
Dec 09, 2020 Buy 75 000 Rodino Iii Peter W. Options
Dec 09, 2020 Buy 75 000 Lintal Ellen M Options
Nov 11, 2020 Buy 300 000 Equels Thomas K. Options
Sep 03, 2020 Buy 12 316 Equels Thomas K. Common Stock
Aug 21, 2020 Buy 10 730 Equels Thomas K. Common Stock
Aug 21, 2020 Buy 10 730 Equels Thomas K. Common Stock
Aug 12, 2020 Buy 50 000 Mitchell William M Options
Aug 12, 2020 Buy 300 000 Equels Thomas K. Options
Aug 12, 2020 Buy 50 000 Appelrouth Stewart Options
Dec 31, 2019 Buy 3 931 Lintal Ellen M Common Stock
Dec 31, 2019 Buy 6 879 Rodino Iii Peter W. Common Stock
Dec 31, 2019 Buy 14 741 Equels Thomas K. Common Stock
Dec 13, 2019 Buy 8 358 Appelrouth Stewart Common Stock
Dec 13, 2019 Buy 8 358 Mitchell William M Common Stock
Dec 13, 2019 Buy 4 789 Lintal Ellen M Common Stock
Dec 13, 2019 Buy 8 381 Rodino Iii Peter W. Common Stock
Dec 13, 2019 Buy 17 960 Equels Thomas K. Common Stock
Nov 29, 2019 Buy 9 503 Appelrouth Stewart Common Stock
Nov 29, 2019 Buy 9 503 Mitchell William M Common Stock
Nov 29, 2019 Buy 5 208 Lintal Ellen M Common Stock
Nov 29, 2019 Buy 9 115 Rodino Iii Peter W. Common Stock
Nov 29, 2019 Buy 19 531 Equels Thomas K. Common Stock
Nov 15, 2019 Buy 8 264 Appelrouth Stewart Common Stock
Nov 15, 2019 Buy 8 264 Mitchell William M Common Stock
Nov 15, 2019 Buy 4 433 Lintal Ellen M Common Stock
Nov 15, 2019 Buy 7 752 Rodino Iii Peter W. Common Stock
INSIDER POWER
93.907
Last 100 transactions
Buy: 4 124 490 | Sell: 68 208 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 93.907.

In total, the insiders bought 4 124 490 and sold 68 208 AIM shares in the last 100 trades.

Click to get the best stock tips daily for free!

About AIM ImmunoTech Inc.

AIM ImmunoTech. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, n... AIM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT